We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$6.9B
AUM Growth
-$199M
Cap. Flow
-$157M
Cap. Flow %
-2.27%
Top 10 Hldgs %
24.04%
Holding
3,083
New
373
Increased
407
Reduced
1,584
Closed
241

Sector Composition

Rank Sector Weight
1 Technology 23.96%
2 Healthcare 12.46%
3 Financials 12.39%
4 Consumer Discretionary 12.33%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUN icon
2401
Huntsman Corp
HUN
$1.81B
$124K ﹤0.01%
4,192
-168
-4% -$4.42K
CTLP
2402
DELISTED
Cantaloupe
CTLP
$124K ﹤0.01%
11,491
-4,685
-29% -$48.5K
BF.A icon
2403
Brown-Forman Class A
BF.A
$13.1B
$123K ﹤0.01%
1,970
-68
-3% -$4.54K
PLRX icon
2404
Pliant Therapeutics
PLRX
$66.9M
$123K ﹤0.01%
7,310
HLF icon
2405
Herbalife
HLF
$1.28B
$123K ﹤0.01%
2,903
-177
-6% -$8.75K
VITL icon
2406
Vital Farms
VITL
$498M
$123K ﹤0.01%
6,985
MDXG icon
2407
MiMedx Group
MDXG
$612M
$123K ﹤0.01%
20,238
-11,255
-36% -$127K
NESR
2408
National Energy Services Reunited Corp
NESR
$3.62B
$123K ﹤0.01%
+9,791
New +$119K
HIFS icon
2409
Hingham Institution for Saving
HIFS
$686M
$123K ﹤0.01%
364
-139
-28% -$43.4K
BYRN icon
2410
Byrna Technologies
BYRN
$97.6M
$122K ﹤0.01%
+5,603
New +$139K
KDNY
2411
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$122K ﹤0.01%
9,583
BPOP icon
2412
Popular Inc
BPOP
$11.3B
$122K ﹤0.01%
1,574
-139
-8% -$10.3K
RLMD icon
2413
Relmada Therapeutics
RLMD
$507M
$122K ﹤0.01%
4,664
APYX icon
2414
Apyx Medical
APYX
$128M
$122K ﹤0.01%
+8,826
New +$92.8K
JAMF
2415
DELISTED
Jamf
JAMF
$122K ﹤0.01%
+3,163
New +$109K
UI icon
2416
Ubiquiti
UI
$35.3B
$121K ﹤0.01%
406
-13
-3% -$4.02K
GEF.B icon
2417
Greif Class B
GEF.B
$4.22B
$121K ﹤0.01%
1,862
ETD icon
2418
Ethan Allen Interiors
ETD
$583M
$121K ﹤0.01%
5,088
-1,659
-25% -$41K
IESC icon
2419
IES Holdings
IESC
$14.9B
$121K ﹤0.01%
2,639
SWIM icon
2420
Latham Group
SWIM
$889M
$120K ﹤0.01%
7,346
ROCC
2421
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$120K ﹤0.01%
4,508
-97
-2% -$1.91K
BCOV
2422
DELISTED
Brightcove, Inc.
BCOV
$120K ﹤0.01%
10,416
+3,607
+53% +$43.6K
CACC icon
2423
Credit Acceptance
CACC
$6.05B
$120K ﹤0.01%
205
-22
-10% -$12K
MCBS icon
2424
MetroCity Bankshares
MCBS
$1.05B
$120K ﹤0.01%
5,721
NDLS icon
2425
Noodles & Co
NDLS
$100M
$120K ﹤0.01%
1,269

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2021 Portfolio in Review

As of Q3 2021, Metropolitan Life Insurance Company (MetLife) held 3,083 positions worth $6.9B, down 2.8% from $7.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q3 2021 filing shows 373 new, 407 increased, 1,584 reduced and 241 closed positions. Its largest new stake was Alphabet (Google) Class C: 878,340 shares worth $117M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2021 buy was Alphabet (Google) Class C: 878,340 shares worth $117M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares Russell 1000 Growth ETF in Q3 2021, an estimated $17.3M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $17.5M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $4.87M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $6.9B portfolio in Q3 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 373 new positions and closed 241 in Q3 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 2.8% quarter-over-quarter to $6.9B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2021, filed 15 Nov 2021.